Eli Lilly is a leader in the market for GLP-1 medicines. The company's Zepbound, indicated for weight loss, is racking up billions in quarterly sales. Its only real competitor in weight management is ...

Only one of these growth stocks is up big so far in 2025. But all three could be huge winners over the next few years.